Rehabilitation Needs in Cancer Treatment-Related Cardiotoxicity.
cardiotoxicity
cardiovascular
chemotherapy
radiation therapy
rehabilitation
survivorship
tyrosine kinase inhibitor
Journal
Seminars in oncology nursing
ISSN: 1878-3449
Titre abrégé: Semin Oncol Nurs
Pays: United States
ID NLM: 8504688
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
pubmed:
28
1
2020
medline:
26
2
2021
entrez:
28
1
2020
Statut:
ppublish
Résumé
To examine and summarize current international guidelines regarding cardiovascular risk reduction before and during cancer therapy, and to discuss the emerging role of cardio-oncology as a subspecialty in cancer care and the role of cardio-oncology rehabilitation. Published articles and guidelines. With improvements in cancer detection and the use of novel adjuvant therapies, an increasing number of individuals now survive a cancer diagnosis. However, for some the cost is high - many survivors are now at higher risk of death from cardiovascular disease than from recurrent cancer. Cardiovascular morbidity and mortality are common and associated with common cancer therapies serially administered in adult oncology care. Timely risk-reduction interventions hold promise in reducing cardiovascular morbidity and mortality. Oncology nurses are the key providers to identify baseline risks, perform necessary referrals, provide individualized teaching, and support the patient within the family and community.
Identifiants
pubmed: 31983487
pii: S0749-2081(20)30001-2
doi: 10.1016/j.soncn.2020.150986
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
150986Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.